Indeed, the global oncology community trusts ESMO to disseminate the latest results of cancer research. Why? Because it is ...

The $25 million award from the Advanced Research Projects Agency for Health (ARPA-H) will be used to develop Cellino's NEBULA ...

It's known that excessive use of earbuds at high volumes can cause hearing loss, so somewhat ironic that the FDA has just ...

The PM Society Digital Awards 2024, an annual event in the healthcare marketing industry sponsored by Twist Health, held its ...

Olorofim is licensed in Europe and Asia to Japanese pharma Shionogi, which paid $100 million upfront for rights to the drug ...

The facility at a business park in Raheen, Limerick, was first announced in 2022 and this is the second time that Lilly has ...

UK biotech F2G has raised $100 million as it prepares to refile its olorofim candidate for invasive fungal infections, which ...

GSK has abandoned its clinical-stage vaccine for herpes simplex virus (HSV) after a disappointing phase 1/2 trial, ceding the ...

GSK's new long-acting drug candidate for severe asthma, depemokimab, reduced the rate of severe attacks by 54% in a pair of ...

Bayer and Boehringer Ingelheim both had new data on their HER2-targeting small-molecule drugs to present at the World ...

There are no FDA-approved therapies for this age group, although, Wegovy has been cleared since 2022 for use in children and ...

G&L taps new hire to lead growth. G&L Healthcare Advisors, a Madison, New Jersey consultancy specialising in regulatory and ...